Please select the option that best describes you:

How do you approach ADT and pelvic lymph node radiation in the salvage setting for patients with a PSA <0.5 ng/mL?  

How do the results of RTOG 0534 presented at ASTRO affect your decision making?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Prostate Cancer Center Of New Jersey
Very well explained. Thanks
Radiation Oncologist at Tennessee Oncology
Regarding the use of nodal RT, how should the time...
Radiation Oncologist at Radiant Oncology
@Daniel E. Spratt: " However, those with PSA <0...
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center
It is not published yet. They did present the data...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Radiation Oncology of Atlanta
Would the presence of high-risk features change yo...
Radiation Oncologist at Mount Sinai Medical Center Miami
I am not a prostate expert, but I can't see how yo...
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center
Nicolas- You have a commonly held viewpoint. I t...
Radiation Oncologist at The Oregon Clinic-Radiation Oncology West
While randomized evidence should always guide disc...
Radiation Oncologist at Allentown Radiation Oncology Associates
@Daniel E. Spratt - has the publication of RTOG 05...
Sign in or Register to read more